KELLY HORTEL: Open Payments
NPI 1942749379 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 88 payments from 11 companies in 2025. Trend: 2023 $897 · 2024 $3,874 · 2025 $1,953
Food & beverage: $1,953
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 23 | $761 |
| Madrigal Pharmaceuticals | 18 | $325 |
| Ipsen Biopharmaceuticals, Inc | 10 | $253 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $228 |
| ABBVIE INC. | 7 | $206 |
| Novo Nordisk Inc | 2 | $41 |
| Intra-Sana Laboratories | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Mirum Pharmaceuticals, Inc. | 1 | $18 |
Products named: REZDIFFRA, IQIRVO, XIFAXAN, MAVYRET, Epclusa, Wegovy, RELTONE 200 MG, OCALIVA.
Industry payments across AZ — which companies pay providers there.
